Stefaan C. De Smedt is a Professor in Physical Pharmacy and Biopharmacy at Ghent University and the head of the Ghent Research Group on Nanomedicines. He studied pharmacy at Ghent University (Belgium) and received his MS degree in pharmaceutical sciences in 1990. He graduated from Ghent University in 1995 and then, joined the pharmaceutical development group of Janssen Research Foundation. Since 1997 he has been a post-doctoral fellow of the Flemish Fund for Scientific Research at the Departments of Pharmacy of respectively Ghent University and the University of Utrecht (Netherlands). In October 1999 he became Professor in Physical Pharmacy and Biopharmacy at Ghent University where he initiated his research on advanced delivery of biologics/nanomedicines and founded the Ghent Research Group on Nanomedicines. Stefaan De Smedt’ s research is at the interface between drug delivery, biophysics, material sciences and physical chemistry. Currently he is Guest Professor at the Shanghai Jiao Tong University, Distinguished Visiting Scientist of the Chinese Academy of Sciences at the University of Science and Technology of China and Specially Appointed Professor of Nanjing Foresty University. He served as dean of the Faculty of Pharmaceutical Sciences at Ghent University from 2010 till 2014. Since 2014 he is a member of the Board of Directors of Ghent University and board member of CRIG (Cancer Research Institute Ghent). Since 2004 Dr. De Smedt serves as the European Associate Editor of the Journal of Controlled Release (JCR); In 2015 he became Editor of JCR (for the region Europe- the Middle East & Africa). He is as member of the Belgian Royal Academy of Medicine (elected 2015) and the European Academy of Sciences (section medicine & life sciences; elected 2018). In 2018 he became awarded Highly Cited Researcher (interdisciplinary sciences) by Web of Science (Thomson Reuters).